Session Details
[D3-A3]Hot topics related to ADC: New Approaches and Innovations
Wed. Mar 5, 2025 3:00 PM - 4:30 PM JST
Wed. Mar 5, 2025 6:00 AM - 7:30 AM UTC
Wed. Mar 5, 2025 6:00 AM - 7:30 AM UTC
Medium Hall(2nd Floor)
Chairman:Masanori Nagata(Astellas Pharma Inc.), Makoto Takahashi(Daiichi Sankyo Co., Ltd.)
[D3-A3-01]Bioanalysis of ADC: Case Study of Measuring Blood Concentration of ADC and its Constituent Parts in Astellas
*Yuji Fujita1, Katsuaki Nitta1, Toshiko Yahata1 (1. Astellas Pharma Inc.)
[D3-A3-02]Bioanalysis and Biotransformation of Antibody Drug Conjugate
*Yuki Kishino1 (1. Daiichi Sankyo Co., Ltd.)
[D3-A3-03]Development of an Analytical Method for Determining the DAR of ADC in Human Plasma Using LC/MS
*Noritaka Hashii1 (1. National Institute of Health Sciences)